EUVIMEDEUVIMED entdecken
Crossref

Anti-HMGCR Immune-Mediated Necrotizing Myopathy: Persistent Weakness Despite Glucocorticoids and Recovery After IVIG

Leila C. Tou, Juan P. Madrid-Calles, Raquel S. Aymerich, Sarah Koraym

Journal of Community Hospital Internal Medicine Perspectives · 17.11.2026 · 16 (6)

DOI: 10.55729/2000-9666.1660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Community Hospital Internal Medicine Perspectives, online erschienen am 17.11.2026. Verfasst von Leila C. Tou und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Statin-associated anti-HMGCR immune-mediated necrotizing myopathy is a rare autoimmune myopathy characterized by progressive proximal weakness and persistent muscle enzyme elevation despite statin discontinuation. Although glucocorticoids are commonly used as initial therapy, biochemical and functional responses may be discordant. Few published cases document this dissociation through serial paired creatine kinase (CK) and standardized strength measurements. This case contributes such data and supports early IVIG escalation when disability persists despite glucocorticoid therapy. Case Description: We present the case of a 71-year-old woman on chronic statin therapy who developed several weeks of progressive proximal weakness with marked creatine kinase elevation. Evaluation demonstrated positive anti-HMGCR antibodies, diffuse symmetric muscle edema on thigh magnetic resonance imaging, electromyographic findings consistent with inflammatory myopathy, and necrotizing myopathy on biopsy, fulfilling the 2018 ENMC classification criteria for anti-HMGCR IMNM. High-dose prednisone led to partial biochemical improvement; at six-week follow-up, CK had declined to 1,683 U/L while hip flexion strength had worsened to MRC grade 2/5, illustrating a quantified CK-strength dissociation. IVIG was initiated at 2 g/kg per cycle every 4 weeks. Progressive strength recovery to 5/5 bilaterally and CK normalization were achieved at one year.

Conclusion

This case provides a prospectively documented, quantified illustration of the CK-strength dissociation, a pattern underreported in the literature. The use of CK alone may be an unreliable marker of disease burden. Strength should be assessed independently at each visit. Early IVIG escalation should be considered when meaningful weakness persists despite glucocorticoid therapy.

Zitieren

APA

Tou, L. C., Madrid-Calles, J. P., Aymerich, R. S., & Koraym, S. (2026). Anti-HMGCR Immune-Mediated Necrotizing Myopathy: Persistent Weakness Despite Glucocorticoids and Recovery After IVIG. Journal of Community Hospital Internal Medicine Perspectives, 16(6). https://doi.org/10.55729/2000-9666.1660

Vancouver

Tou LC, Madrid-Calles JP, Aymerich RS, Koraym S. Anti-HMGCR Immune-Mediated Necrotizing Myopathy: Persistent Weakness Despite Glucocorticoids and Recovery After IVIG. Journal of Community Hospital Internal Medicine Perspectives. 2026;16(6). doi:10.55729/2000-9666.1660

BibTeX
@article{Tou2026,
  author = {Tou, Leila C. and Madrid-Calles, Juan P. and Aymerich, Raquel S. and Koraym, Sarah},
  title = {Anti-HMGCR Immune-Mediated Necrotizing Myopathy: Persistent Weakness Despite Glucocorticoids and Recovery After IVIG},
  journal = {Journal of Community Hospital Internal Medicine Perspectives},
  year = {2026},
  volume = {16},
  number = {6},
  doi = {10.55729/2000-9666.1660}
}
Kostenlos starten →